Search

everythinglearnresearchcommunity

for

Search:↓

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

DHT, a testosterone byproduct, causes male pattern baldness.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Finasteride, a hair loss medication, may be linked to stroke in young men.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

New treatments for male hypogonadism are effective and should be personalized.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

A male with aromatase deficiency improved bone health with estradiol treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A group has developed therapies that show promise for treating cancer and various other conditions.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Septin4 helps kill colon cancer cells by working with the protein BAX.